Chemours Co (CC): what the price assumes

boothcheck covers Chemours Co (CC) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/CC

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

How unusual the bet is: n/a

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that call it expensive: Asset, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 4.0%); the inversion above states its own rate.

Per-Model Detail (n=5)

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 2.7%); the trailing year was depressed.

Bullet Takeaways

• Three businesses share one ticker: titanium dioxide at 40% of revenue, the refrigerant lines of Opteon, Freon and foam blowing agents at about 35% together, and advanced materials at roughly 23%, and only the refrigerant side is currently growing.
• Leverage is the governing fact, with about 3.61 billion dollars of net debt and a March refinancing that put 700 million dollars of 7.875% senior unsecured notes due 2034 in place of 5.375% and 5.750% paper.
• Two dated items to follow: a global titanium dioxide price increase effective April 1, 2026, and the June settlement with the EPA that fixes a civil penalty and a fifteen-year mitigation commitment.

Bull Case

Most of the standard valuation apparatus simply cannot see this company at the moment. Trailing earnings are negative and book value has been ground down to roughly $1.43 a share, so every approach that begins with profit or with net assets has nothing to divide into. The only comparison that still produces an answer measures the price against revenue, and on that basis the market value sits well under what a sector revenue multiple would suggest for $5.82 billion of sales. That is a narrow foundation to build on. It is also, stated plainly, the bull case: the buyer is acquiring the revenue at the bottom of the earnings cycle rather than the top.

The part of the company that is not cyclical is the part that is growing. Thermal and Specialized Solutions lifted first-quarter net sales 22% to $568 million from $466 million, on price up 11% and volume up 9%, and management called it a record first quarter with double-digit growth in Opteon. Full-year 2025 repeated the pattern from a smaller base, with segment sales rising on 5% higher selling prices and 8% more volume, driven by Opteon aftermarket demand.

What makes that durable is not commercial skill so much as chemistry and a legislated clock. The 10-K describes a franchise that has "held a leading position in the fluorochemicals market since the commercial introduction of Freon in 1930" and has since been "at the forefront of new technology research for lower GWP and lesser ozone-depleting potential products". Refrigerant transitions are mandated rather than chosen. Every air conditioner and vehicle built to the new standard creates decades of aftermarket demand for the specific molecule it was designed around, and the aftermarket is where the pricing is.

On the pigment side, the trough is industry-wide rather than company-specific, which matters for how a recovery would arrive. Across the broader chemical cohort, OLIN (OLN) is running a -1.7% operating margin, HUNTSMAN (HUN) -3.3%, CELANESE (CE) -7.8%, LYONDELLBASELL (LYB) -1.0% and WESTLAKE (WLK) -15.7%. Nobody in this neighbourhood is earning their cost of capital. Chemours announced a global titanium dioxide price increase effective April 1, 2026, continuing December actions, and had already achieved a 3% sequential price gain in the first quarter. Pricing moves in a commodity pigment when the marginal producer stops adding tons.

Two pieces of the discount have started converting into known quantities. The company received about 287 million dollars of initial net proceeds from the sale of the Kuan Yin site and said the money positions it to pay down 140 million euros of debt. And in June it settled with the EPA and West Virginia regulators over PFAS discharges at three operating sites for a 22.5 million dollar civil penalty payable across 2026 to 2028, of which 15 million was already accrued, plus 90 million dollars of mitigation projects spread over fifteen years. When a stock trades at a discount built mostly on liabilities nobody can size, replacing an unbounded worry with a payment schedule is worth more than the payment itself.

The bear is right that a through-cycle operating margin near 2.7% is thin for a business carrying this much debt. The rejoinder is arithmetic rather than optimism: the mix is shifting toward the segment that grows on a regulatory schedule, and margin recovery from a trough tends to arrive faster than the revenue that carries it.

Bear Case

Start with the largest revenue line, because it is the one not participating. Titanium dioxide is 40% of sales, and in 2025 its segment net sales fell to $2,429 million from $2,572 million while segment adjusted profitability dropped by more than half, to $145 million from $301 million, taking the segment margin from 12% down to 6%. The first quarter of 2026 was worse: segment adjusted profit of $18 million against $50 million a year earlier, a margin of 3%. The business that supplies the biggest share of revenue is, right now, barely contributing.

Advanced Performance Materials is not filling the hole either. Its first-quarter net sales fell 17% to $243 million, with volumes down 19%, following a 2025 in which segment sales slipped to $1,263 million from $1,326 million and segment adjusted profit fell to $108 million from $160 million. Two of the three segments are contracting. The entire forward story therefore rests on refrigerants, and the price is written as though that will be enough.

Held against roughly 40 times company-wide operating income measured on through-the-cycle margins, what the price embeds is essentially today's economics persisting for about 6.6 years at a growth pace the company has not historically delivered. Treat that as a rough boundary rather than a measurement, because a business with negative trailing earnings does not invert cleanly. Even as a rough boundary it is demanding: of comparable fast growers, only about a quarter sustained that pace over a similar span.

The financing is where the fragility becomes concrete. Net debt of about 3.61 billion dollars is roughly 22.8 times operating profit, measured on through-the-cycle earnings rather than the trailing loss, and that same through-cycle operating profit covers only about 0.6 times the interest bill. The cost of carrying it went up this year by deliberate choice: in March the company issued 700 million dollars of 7.875% senior unsecured notes due 2034 and used the proceeds to retire 188 million dollars of 5.750% notes due 2028 and to fund redemption of the 5.375% notes due 2027. The first-quarter net loss widened to $29 million, or $0.19 a share, from $5 million a year earlier, which management attributed in part to increased financing costs from that offering. Refinancing near-dated maturities at a materially higher coupon is prudent balance-sheet management and it is also a permanent transfer of several years of segment profit to bondholders.

The credit agreement leaves less room than the size of the company suggests. The revolver requires the company "to not exceed a maximum senior secured net leverage ratio of 2.00 to 1.00 in any period of four consecutive fiscal quarters through the date of maturity", and the 10-K spells out that a default there "would allow the lenders under the Senior Secured Credit Facilities to declare all loans immediately due and payable and to institute foreclosure proceedings against their collateral".

Finally, the June settlement resolved federal claims at three operating sites; it did not resolve the legacy category. The cost-sharing arrangement with the former parent still contemplates "Fines and/or penalties from governmental agencies for legacy EID PFAS emissions or discharges prior to the spin-off" along with natural resources damages claims. Against all of that, the equity interests the company holds outside its operating businesses come to about 166 million dollars, roughly 6% of the market value. That is the floor beneath an operating impairment, and it is small next to what sits above it in the capital structure.

Valuation

Chemours has reached the point in its cycle where most valuation arithmetic quietly stops functioning. Trailing earnings are negative. Book value per share is around $1.43, so the methods that add excess returns to net assets are working from almost no base and produce numbers that should not be taken seriously in either direction. What remains is a comparison against revenue. That lens reads 5.82 billion dollars of sales against a market value near 2.6 billion dollars. It is worth knowing that this is the only standard method still returning a usable answer, and worth remembering that it is also the one method structurally blind to whether the revenue earns anything.

So the more honest anchor is what the price assumes. Measured against through-the-cycle operating margins rather than the trailing loss, the market is paying roughly 40 times company-wide operating income, and that implies today's economics holding for something in the region of 6.6 years. Take the horizon loosely. Working backwards from a price is never precise when the starting earnings are negative, and the useful part is the direction rather than the decimal: the price is not paying for a trough, it is paying for a recovery that arrives and then persists.

The segment build shows where such a recovery would have to come from. Titanium dioxide contributes 40% of revenue and earned a 6% segment margin in 2025 against 12% the year before. Advanced materials contributes about 23% and moved from a 12% segment margin to 9%. The refrigerant lines together make up roughly 35% and are the only ones growing, with first-quarter segment sales up 22%. Whole-company through-cycle operating margin sits near 2.7%; the trailing twelve months were an operating loss. Those are two very different pictures of the same company, and which one is the correct description is the question the price is answering with a guess.

Cohort context does not resolve it, mostly because the entire cohort is in the same condition. OLIN (OLN) at a -1.7% operating margin, HUNTSMAN (HUN) at -3.3%, CELANESE (CE) at -7.8% and WESTLAKE (WLK) at -15.7% are not a benign backdrop against which Chemours looks unusually troubled; they are evidence that industrial chemical demand is broadly weak. That cuts both ways. A cyclical trough shared by everyone tends to end for everyone, and a company with this much debt has less time to wait for it than its peers do.

Which brings the section to the balance sheet, where it belongs for this name. Net debt of about 3.61 billion dollars stands at roughly 22.8 times operating profit on through-the-cycle earnings, with liquid assets of about 563 million dollars and through-cycle operating profit covering only around 0.6 times the interest bill. The March refinancing pushed the nearest maturities out to 2034 at 7.875%, and roughly 287 million dollars of asset-sale proceeds are earmarked against debt. The equity here is a residual claim on a recovery, sitting behind a fixed obligation that does not care whether the recovery is early or late.

Catalysts

The clearest recent event was legal rather than commercial. On June 24, 2026 Chemours announced a settlement with the U.S. EPA, joined by the West Virginia Department of Environmental Protection, resolving federal claims over PFAS discharges and related alleged non-compliance primarily at the Washington Works, Fayetteville Works and Chambers Works sites. The terms are specific: a 22.5 million dollar civil penalty payable in three annual installments across 2026, 2027 and 2028, of which 15 million had already been accrued, plus 90 million dollars of mitigation projects funded over fifteen years. The settlement covers three operating sites and does not close out the legacy category, but it converts an open-ended regulatory exposure at those sites into a payment schedule the market can price.

March brought a financing decision with a longer shadow. The company completed a private offering of 700 million dollars of 7.875% senior unsecured notes due 2034, using the proceeds and cash on hand to redeem 188 million dollars of 5.750% notes due 2028 at a redemption price of about 189.8 million, and to fund redemption of the outstanding 5.375% notes due 2027 at roughly 500.3 million. Maturity risk went down and the annual interest bill went up, and the first-quarter loss reflected the change.

First-quarter results, reported May 5, 2026, showed net sales of $1,381 million against $1,368 million a year earlier, with price up 2% and currency up 3% offsetting a 4% volume decline attributed to an operational outage in advanced materials and to weak cyclical end markets. Two forward markers came with it: a global titanium dioxide price increase effective April 1, 2026, following December actions and a 3% sequential price gain already achieved in the quarter, and about 287 million dollars of initial net proceeds from the Kuan Yin site sale earmarked toward paying down 140 million euros of debt. Whether the April pigment increase holds through the second quarter is the single most informative thing the next report will say.

Peer Cohorts (Per Segment, With Filing Citations)

Thermal & Specialized Solutions (reported)

• OLN (Olin Corporation)
• FY2025 10-K: …the Chlor Alkali Products and Vinyls segment to generate caustic soda production and sales. Chlorine and caustic soda used in our Epoxy segment are transferred at cost from the Chlor Alkali Products and Vinyls segment. The following table lists the principal products and services of our Epoxy segment: Products &…
• FY2025 10-K: …treatment activities are higher. Our Epoxy segment also serves a number of applications which experience their highest level of activity during the spring and summer months, particularly civil engineering and protective coatings and other construction materials, including composites and flooring. RAW MATERIALS Basic…
• HUN (Huntsman Corporation)
• FY2025 10-K: …of suppliers. We consume certain amines produced by our Performance Products segment and isocyanates produced by our Polyurethanes segment, which we use to formulate our Advanced Materials products. For additional information about our risks of raw material supply chain disruptions, see "Part I. Item 1A. Risk…
• FY2025 10-K: …and toughening technologies, backed by application and process manufacturing knowledge. Our product offering allows for reliable and competitive solutions, with a strong ARALDITE ® and PROBIMER ® brand reputation, a robust supply chain and a specialized distribution channel to fulfill customers' expectant demand for…
• CE (CELANESE CORPORATION)
• FY2025 10-K: …and withstanding deformation. Nylon compounds are used in a range of applications including automotive, consumer, electrical, electronic and industrial. These value-added applications in diverse end uses support the business' global growth objectives. POM, PBT and LFRT are used in a broad range of…
• FY2025 10-K: …Contents allows us to create a demand pull for our solutions. This business segment also includes 17 strategic affiliates that complement our global reach, improve our ability to capture growth opportunities in emerging economies. • Key Products Elastomers. Vamac ® EAE, our elastomer brand, is primarily used in…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …use) emissions by 30 percent by 2035, measured from the Company's 2017 baseline year, in order to achieve net-zero operations by 2050, and to innovate to provide products that enable energy savings and GHG emissions reductions to customers and end-users. Eastman focuses on the triple challenge of climate change,…
• FY2025 10-K: Eastman's strategy is to target industries and markets where the Company can leverage its application development expertise to develop product offerings to provide differentiated value that addresses current and future customer and market needs. The Company's strategic marketing approach and capabilities leverage the…
• WLK (Westlake Corporation)
• FY2025 10-K: …outdoor living products include Zuri ® Premium Decking. PVC Pipe. We manufacture and sell PVC pipe ranging in sizes from ½ inch to 36 inches in diameter, in gasketed, solvent welded, and restrained joint configurations. Our pipe products are used in residential water and sewer applications; municipal potable water…
• FY2025 10-K: …reducing waste at our facilities, incorporating more recycled content into our products, seeking to incorporate renewable and bio-based materials, and producing products that support greater efficiency and durability. Housing and Infrastructure Products Business Our HIP segment is primarily comprised of residential…

Titanium Technologies (reported)

• OLN (Olin Corporation)
• FY2025 10-K: ,000 square foot production facility located in Manitowoc, WI, is included in Olin's Winchester segment. The acquisition was financed with cash on hand. On September 18, 2025, we announced a mutual decision with Mitsui & Co., Ltd. to end our joint venture, Blue Water Alliance, by the end of 2025. This decision was…
• FY2025 10-K: …amounts through 2032. The impact of the 45V Tax Credit is included within the Chlor Alkali Products and Vinyls segment results. 29 Table of Contents Subsequent Event - Litigation Matter In April 2023, Shintech filed a lawsuit against Olin Corporation and its wholly owned subsidiary, Blue Cube Operations LLC. Shintech…
• HUN (Huntsman Corporation)
• FY2025 10-K: …Anhydride Manufacturing Facility Ashtabula, Ohio Advanced Materials Formulating and Synthesis Facility Duxford, U.K. Advanced Materials Formulating and Synthesis Facility McIntosh, Alabama Advanced Materials Formulating and Synthesis Facility Monthey, Switzerland Advanced Materials Formulating and Synthesis Facility…
• FY2025 10-K: …Facility Wilton, U.K. Polyurethanes Aniline and Nitrobenzene Manufacturing Facilities Rotterdam, The Netherlands (1) Polyurethanes MDI and Polyols Manufacturing Facilities and Shared Services Center Geismar, Louisiana (5) Polyurethanes and Performance Products MDI, Nitrobenzene (4) , Aniline (4) , Polyols and Maleic…
• CE (CELANESE CORPORATION)
• FY2025 10-K: Our VAntage ® 2 technology enables us to increase VAM capacity to meet growing customer demand globally with minimal investment. VAM produced by the acetyl chain business is a primary raw material for our emulsion polymers and EVA polymers businesses. Our acetate tow business is a leading global producer and supplier…
• FY2025 10-K: …and withstanding deformation. Nylon compounds are used in a range of applications including automotive, consumer, electrical, electronic and industrial. These value-added applications in diverse end uses support the business' global growth objectives. POM, PBT and LFRT are used in a broad range of…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma; and consumables end-markets. Key technology platforms for this segment include cellulosic biopolymers, copolyesters, and PVB and…
• FY2025 10-K: …at the Kingsport, Tennessee site, which is supplied from Eastman's vertically integrated gasification facility and is the largest and most integrated acetate tow site in the world. The Fibers segment also expects to benefit from Eastman's carbon renewal technology, which enables the substitution of fossil feedstock…
• WLK (Westlake Corporation)
• FY2025 10-K: …reducing waste at our facilities, incorporating more recycled content into our products, seeking to incorporate renewable and bio-based materials, and producing products that support greater efficiency and durability. Housing and Infrastructure Products Business Our HIP segment is primarily comprised of residential…
• FY2025 10-K: …2025-01-01 2025-12-31 0001262823 us-gaap:OperatingSegmentsMember wlk:HousingProductsMember wlk:HousingAndInfrastructureProductsMember 2024-01-01 2024-12-31 0001262823 us-gaap:OperatingSegmentsMember wlk:HousingProductsMember wlk:HousingAndInfrastructureProductsMember 2023-01-01 2023-12-31 0001262823…
• LYB (LYONDELLBASELL INDUSTRIES N.V.)
• FY2025 10-K: Channelview, Texas (1)(2) I&D Chocolate Bayou (Alvin), Texas O&P-Americas Clinton, Iowa O&P-Americas Corpus Christi, Texas O&P-Americas Edison, New Jersey Technology La Porte, Texas (3) O&P-Americas La Porte, Texas (3) I&D Lake Charles, Louisiana O&P-Americas Lake Charles, Louisiana (4) O&P-Americas Matagorda (Bay…
• FY2025 10-K: . Senior Director Advanced Polymer Solutions US/Canada Region from October 2018 to October 2020. Torkel Rhenman, 62 Executive Vice President, Advanced Polymer Solutions since October 2022. Executive Vice President, Intermediates & Derivatives, and Refining from August 2020 to September 2022. Executive Vice President,…
• AVNT (AVIENT CORPORATION)
• FY2025 10-K: NT CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Note 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of Business We are an innovator of materials solutions to help our customers succeed, while enabling a sustainable world. Our products include specialty engineered…
• FY2025 10-K: …No customer accounted for more than 3% of our consolidated revenues in 2025. Research and Development One of our strategic drivers is to "Amplify Innovation," and we have substantial technology and development capabilities, powered by approximately 1,100 employees serving in technical capacities, approximately 120 of…
• HXL (HEXCEL CORP /DE/)
• FY2025 10-K: …of which we have been unable to recover or offset, as well as transportation and performance delays. We continue to monitor the availability (including transportation) and price (including impacts of tariffs and inflation) of raw materials on a regular basis, as well as any potential impact on our operations. Our…
• FY2025 10-K: .0 Operating income (loss) $ 215.0 $ 39.6 $ ( 68.5 ) $ 186.1 Year Ended December 31, 2023 Net sales to external customers $ 1,474.2 $ 314.8 $ - $ 1,789.0 Intersegment sales 70.6 2.4 ( 73.0 ) - Total sales 1,544.8 317.2 ( 73.0 ) 1,789.0 Cost of sales 1,165.1 261.1 ( 70.4 ) 1,355.8 Gross margin 379.7 56.1 ( 2.6 ) 433.2…

Advanced Performance Materials (reported)

• AVNT (AVIENT CORPORATION)
• FY2025 10-K: NT CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Note 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of Business We are an innovator of materials solutions to help our customers succeed, while enabling a sustainable world. Our products include specialty engineered…
• FY2025 10-K: …link between large chemical producers (our raw material suppliers) and designers, assemblers and processors of polymers (our customers). We believe that our role in the value chain continues to become more vital as our customers increasingly need reliable suppliers with global reach, a local touch, and highly…
• CE (CELANESE CORPORATION)
• FY2025 10-K: Asia and consist of 51 global production facilities and an additional 20 strategic affiliate production facilities. As of December 31, 2025, we employed 11,434 people worldwide. Business Segment Overview We operate principally through two business segments: Engineered Materials and the Acetyl Chain. See Business…
• FY2025 10-K: …Contents allows us to create a demand pull for our solutions. This business segment also includes 17 strategic affiliates that complement our global reach, improve our ability to capture growth opportunities in emerging economies. • Key Products Elastomers. Vamac ® EAE, our elastomer brand, is primarily used in…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …and assess performance of the Company. The CODM evaluates segment operating performance, and makes resource allocation and performance evaluation decisions, based on Adjusted EBIT, defined as the GAAP measure earnings before interest and taxes ("EBIT"), adjusted for non-core, unusual, or non-recurring items. These…
• FY2025 10-K: …polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma; and consumables end-markets. Key technology platforms for this segment include cellulosic biopolymers, copolyesters, and PVB and…
• HUN (Huntsman Corporation)
• FY2025 10-K: …of suppliers. We consume certain amines produced by our Performance Products segment and isocyanates produced by our Polyurethanes segment, which we use to formulate our Advanced Materials products. For additional information about our risks of raw material supply chain disruptions, see "Part I. Item 1A. Risk…
• FY2025 10-K: …aluminum panels and other steel materials to lighten structures in aerospace, automotive and other transportation. Our Advanced Materials segment is characterized by the breadth of our product offering, our expertise in complex chemistry, our long-standing relationships with our customers, our ability to develop and…
• ROG (Rogers Corporation)
• FY2025 10-K: …following strategic operating segments: AES and EMS. Our remaining operations, which represent our non-core businesses, are reported in the Other operating segment. We believe this structure aligns our external reporting presentation with how we currently manage and view our business internally. Our CODM is the…
• FY2025 10-K: …industrial (e.g., variable frequency drives), connected devices (e.g., mobile internet devices and thermal solutions) and wired infrastructure (e.g., computing and internet protocol infrastructure) markets. We believe these materials have characteristics that offer performance and other functional advantages in many…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.